Repo! The Genetic Opera
A worldwide epidemic encourages a biotech company to launch an organ-financing program similar in nature to a standard car loan. The repossession clause is a killer, however.
| Domestic | |||
|---|---|---|---|
| Market | Release Date | Opening | Gross |
| Domestic | Nov 7, 2008 | $53,684 | $146,750 |
| Europe, Middle East, and Africa | |||
|---|---|---|---|
| Market | Release Date | Opening | Gross |
| Czech Republic | Nov 20, 2008 | $6,269 | $6,470 |
| Romania | Jul 10, 2009 | – | $2,199 |
| Slovakia | Feb 19, 2009 | – | $689 |
| Spain | Jan 1, 2009 | $14,835 | $26,079 |
| Asia Pacific | |||
|---|---|---|---|
| Market | Release Date | Opening | Gross |
| Australia | Feb 5, 2009 | $2,303 | $5,939 |
